Products

  • ScheBo® • Tumor M2-PK™ Stool Test – Home sampling with laboratory finding

    Who is recommended for screening?

    for every woman and man over 45, at a young age for those with a family history of colon cancer, smokers, overweight, for those on a low-fiber diet,
    to supplement the stool blood test and to control it if necessary

    The main advantages of the ScheBo® • Tumor M2-PK™ Stool Test are:

    • High sensitivity
    • High specificity
    • Not dependend on occult blood
    • Detects bleeding or non-bleeding bowel polyps, especially >1cm
    • Detects bleeding or non-bleeding bowel tumours
    • Not affected by particular foods
    • No special diet required
    • No false results from haemorrhoids or other sources of blood in the bowel
    • A single pea-sized sample is sufficient

     

     

    41.83
  • ScheBo® • Tumor M2-PK™ Stool Quick Test – Home sampling with laboratory finding within 5 business days

    Who is recommended for screening?

    for every woman and man over 45, at a young age for those with a family history of colon cancer, smokers, overweight, for those on a low-fiber diet,
    to supplement the stool blood test and to control it if necessary

    The main advantages of the ScheBo® • Tumor M2-PK™ Stool Quick Test are:

    • High sensitivity
    • High specificity
    • Not dependend on occult blood
    • Detects bleeding or non-bleeding bowel polyps, especially >1cm
    • Detects bleeding or non-bleeding bowel tumours
    • Not affected by particular foods
    • No special diet required
    • No false results from haemorrhoids or other sources of blood in the bowel
    • A single pea-sized sample is sufficient
    43.04
  • Combined Rapid Test: M2-PK™ + Hb
    Enzyme Biomarker M2-PK + Immunological Faecal Occult Blood Test (iFOBT)

    The strength of the new ScheBo® • 2 in 1 Quick™ test (M2-PK + Hb) particularly lies in the fact that the enzyme biomarker M2-PK and the human haemoglobin (Hb) are very different biomarkers that are completely independent of one another. Therefore they each make their own important contribution to bowel cancer screening. By simultaneously testing for M2-PK and Hb both non-bleeding and bleeding colon cancers and polyps can be detected.

    Regagens are also included. On-site monitoring can be carried out. Get results within 15 minutes.

     

    43.04
  • ScheBo® • Pancreas Elastase 1 Quick™ Test

    Indications for use of the ScheBo® · Pancreas Elastase 1 Quick™ test:

    • Diagnosis/exclusion of pancreatic involvement in association with gastrointestinal symptoms: e.g., Maldigestion (Steatorrhoea/Diarrhoea), Abdominal Pain or ´Failure to Thrive”
    • Diagnosis/exclusion of exocrine pancreatic insufficiency in: e.g., chronic Pancreatitis, Cystic Fibrosis, Diabetes, Coeliac Disease, Irritable Bowel Syndrome (IBS), Infl ammatory Bowel Diseases (IBD), Cholelithiasis (Gallstones), Osteoporosis or Papillary Stenosis
    43.04
  • ScheBo® Pancreas Elastase 1 Quick – With reagent

    The painless, 15 minute immunoassay for visual detection of pancreas elastase 1 (PE-1).

    Indications for use of the ScheBo® · Pancreas Elastase 1 Quick™ test:

    • Diagnosis/exclusion of pancreatic involvement in association with gastrointestinal symptoms: e.g., Maldigestion (Steatorrhoea/Diarrhoea), Abdominal Pain or ´Failure to Thrive”
    • Diagnosis/exclusion of exocrine pancreatic insufficiency in: e.g., chronic Pancreatitis, Cystic Fibrosis, Diabetes, Coeliac Disease, Irritable Bowel Syndrome (IBS), Infl ammatory Bowel Diseases (IBD), Cholelithiasis (Gallstones), Osteoporosis or Papillary Stenosis

    43.04